Australian Clinical Labs (ASX:ACL) Gross-Profit-to-Asset % : 116.22% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Australian Clinical Labs Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Australian Clinical Labs's annualized Gross Profit for the quarter that ended in Dec. 2023 was A$675.6 Mil. Australian Clinical Labs's average Total Assets over the quarter that ended in Dec. 2023 was A$581.3 Mil. Therefore, Australian Clinical Labs's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 116.22%.

Australian Clinical Labs Gross-Profit-to-Asset % Historical Data

The historical data trend for Australian Clinical Labs's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Australian Clinical Labs Gross-Profit-to-Asset % Chart

Australian Clinical Labs Annual Data

Trend

Dec20

Jun21

Jun22

Jun23

Gross-Profit-to-Asset %

118.39

141.77

93.79

Australian Clinical Labs Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			187.85	75.05	119.81	67.95	116.22

Competitive Comparison of Australian Clinical Labs's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Australian Clinical Labs's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Australian Clinical Labs's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Australian Clinical Labs's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Australian Clinical Labs's Gross-Profit-to-Asset % falls into.

Australian Clinical Labs Gross-Profit-to-Asset % Calculation

Australian Clinical Labs's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Jun. 2023 )	/	( (Total Assets (A: Jun. 2022 )	+	Total Assets (A: Jun. 2023 ))	/ count )
	=	566.02	/	( (628.042	+	578.913)	/ 2 )
	=	566.02	/	603.4775
	=	93.79 %

Australian Clinical Labs's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	675.632	/	( (578.913	+	583.723)	/ 2 )
	=	675.632	/	581.318
	=	116.22 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Australian Clinical Labs Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Australian Clinical Labs's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Australian Clinical Labs (ASX:ACL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Australian Clinical Labs Ltd (ASX:ACL) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1868-1892 Dandenong Road, Clayton, VIC, AUS, 3168

Website

https://www.clinicallabs.com.au

Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.

Australian Clinical Labs (ASX:ACL) Headlines

No Headlines